Dr Martens has posted record revenue in the year to end March when it sold more pairs of boots, shoes and sandals than at any time in its 62-year history.
Revenue was up 18% to £908.3 million in the period while adjusted pre-tax profit climbed by 43% to £214.3 million.
Dr Martens sold 14.1 million pairs of footwear, which marked a 1.4 million uplift on the previous year, and twice as many as four years ago.
The most popular items were the brand’s original 1460 boot, 1461 shoe and 2976 Chelsea Boot.
The results meant that Dr Martens hit all the targets set at the time of its IPO in January last year despite headwinds such as factory and store closures, shipping delays and higher costs caused by the pandemic.
The company has also highlighted its scale of opportunity in international markets. While Dr Martens sold 32 pairs per thousand people in the established market of the UK last year, it sold 17 pairs per thousand in the US, and just four pairs per thousand in Japan.
